# S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer

> **NCT00088816** · PHASE2 · UNKNOWN · sponsor: **Kyoto University** · enrollment: 50 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** tegafur-gimeracil-oteracil potassium
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00088816
- **Lead sponsor:** Kyoto University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-04
- **Primary completion:** 2008-03
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00088816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00088816, "S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00088816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*